Glenview Trust’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$601K Sell
1,269
-25
-2% -$12.6K 0.01% 346
2025
Q4
$604K Sell
1,294
-102
-7% -$47.4K 0.01% 342
2025
Q3
$595K Sell
1,396
-59
-4% -$22.9K 0.01% 353
2025
Q2
$557K Buy
1,455
+4
+0.3% +$1.44K 0.01% 360
2025
Q1
$501K Buy
1,451
+32
+2% +$10.3K 0.01% 358
2024
Q4
$426K Hold
1,419
0.01% 374
2024
Q3
$577K Sell
1,419
-342
-19% -$125K 0.01% 336
2024
Q2
$566K Buy
1,761
+342
+24% +$111K 0.01% 325
2024
Q1
$473K Sell
1,419
-232
-14% -$70.9K 0.01% 354
2023
Q4
$447K Sell
1,651
-727
-31% -$180K 0.01% 355
2023
Q3
$585K Hold
2,378
0.02% 292
2023
Q2
$722K Buy
2,378
+712
+43% +$198K 0.02% 271
2023
Q1
$439K Hold
1,666
0.01% 334
2022
Q4
$400K Buy
1,666
+5
+0.3% +$1.12K 0.01% 328
2022
Q3
$305K Buy
+1,661
New +$331K 0.01% 347

Other funds holding HCA

Glenview Trust's HCA Position: Q1 2026 in Review

Glenview Trust reduced its HCA Healthcare (HCA) stake by 1.9% in Q1 2026, selling an estimated $12.6K and leaving 1,269 shares worth $601K. The position accounts for 0.01% of the portfolio, ranked #346.

Glenview Trust first reported a position in HCA in Q3 2022 and has held it in 15 quarters since. The position peaked at $722K in Q2 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Glenview Trust held 1,269 shares of HCA Healthcare worth $601K as of Q1 2026.
  • Glenview Trust sold 25 HCA Healthcare shares in Q1 2026, an estimated $12.6K.
  • HCA Healthcare made up 0.01% of Glenview Trust's portfolio in Q1 2026, its #346 holding.
  • Glenview Trust first reported a position in HCA Healthcare in Q3 2022 and has held it in 15 quarters since.
  • Glenview Trust's HCA Healthcare position peaked at $722K in Q2 2023.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.